WallStreetZenWallStreetZen

NASDAQ: IPSC
Century Therapeutics Inc Stock

$3.00-0.29 (-8.81%)
Updated Jul 17, 2024
IPSC Price
$3.00
Fair Value Price
$0.04
Market Cap
$248.54M
52 Week Low
$1.28
52 Week High
$5.51
P/E
-1.36x
P/B
1.4x
P/S
190.07x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.37M
Earnings
-$133.47M
Gross Margin
100%
Operating Margin
-9,683.28%
Profit Margin
-9,742.4%
Debt to Equity
0.96
Operating Cash Flow
-$89M
Beta
1.18
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IPSC Overview

Century Therapeutics Incorporated is a biotech company developing transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also advancing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma. Century Therapeutics was founded in 2018 and is headquartered in Philadelphia, PA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IPSC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IPSC ($3.00) is overvalued by 8,183.12% relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
IPSC ($3.00) is not significantly undervalued (8,183.12%) relative to our estimate of its Fair Value price of $0.04 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IPSC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IPSC due diligence checks available for Premium users.

Be the first to know about important IPSC news, forecast changes, insider trades & much more!

IPSC News

Valuation

IPSC fair value

Fair Value of IPSC stock based on Discounted Cash Flow (DCF)
Price
$3.00
Fair Value
$0.04
Overvalued by
8,183.12%
IPSC ($3.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IPSC ($3.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IPSC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IPSC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.36x
Industry
-21.17x
Market
30.24x

IPSC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.4x
Industry
6.35x
IPSC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IPSC's financial health

Profit margin

Revenue
$855.0k
Net Income
-$28.1M
Profit Margin
-3,282.1%
IPSC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
IPSC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$348.5M
Liabilities
$170.6M
Debt to equity
0.96
IPSC's short-term assets ($199.81M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IPSC's short-term assets ($199.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IPSC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$30.2M
Investing
$11.5M
Financing
$18.2M
IPSC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IPSC vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IPSC$248.54M-8.81%-1.36x1.40x
GOSS$246.58M-12.80%-1.09x9.23x
TSVT$245.20M-2.85%-1.10x1.18x
DSGN$251.97M-1.98%-4.25x0.93x
CBUS$252.56M-1.45%-0.40x0.91x

Century Therapeutics Stock FAQ

What is Century Therapeutics's quote symbol?

(NASDAQ: IPSC) Century Therapeutics trades on the NASDAQ under the ticker symbol IPSC. Century Therapeutics stock quotes can also be displayed as NASDAQ: IPSC.

If you're new to stock investing, here's how to buy Century Therapeutics stock.

What is the 52 week high and low for Century Therapeutics (NASDAQ: IPSC)?

(NASDAQ: IPSC) Century Therapeutics's 52-week high was $5.51, and its 52-week low was $1.28. It is currently -45.55% from its 52-week high and 134.38% from its 52-week low.

How much is Century Therapeutics stock worth today?

(NASDAQ: IPSC) Century Therapeutics currently has 82,847,375 outstanding shares. With Century Therapeutics stock trading at $3.00 per share, the total value of Century Therapeutics stock (market capitalization) is $248.54M.

Century Therapeutics stock was originally listed at a price of $22.83 in Jun 18, 2021. If you had invested in Century Therapeutics stock at $22.83, your return over the last 3 years would have been -86.86%, for an annualized return of -49.16% (not including any dividends or dividend reinvestments).

How much is Century Therapeutics's stock price per share?

(NASDAQ: IPSC) Century Therapeutics stock price per share is $3.00 today (as of Jul 17, 2024).

What is Century Therapeutics's Market Cap?

(NASDAQ: IPSC) Century Therapeutics's market cap is $248.54M, as of Jul 18, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Century Therapeutics's market cap is calculated by multiplying IPSC's current stock price of $3.00 by IPSC's total outstanding shares of 82,847,375.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.